Education
About Us
Working with TipRanks
Follow Us
Dyne Therapeutics (DYN)
NASDAQ:DYN
| Dec 25 | Dec 24 | Dec 23 | Dec 22 | Dec 21 | |
|---|---|---|---|---|---|
| Income Statement | |||||
| Total Revenue | $ 0.00 | $ 0.00 | $ 0.00 | $ 0.00 | $ 0.00 |
| Gross Profit | $ -2.05M | $ -2.24M | $ -2.46M | $ 0.00 | $ 0.00 |
| Operating Income | $ -468.18M | $ -343.89M | $ -242.16M | $ -170.96M | $ -150.03M |
| EBITDA | $ -437.97M | $ -315.18M | $ -233.48M | $ -169.28M | $ -148.94M |
| Net Income | $ -446.21M | $ -317.42M | $ -235.94M | $ -168.10M | $ -149.29M |
| Balance Sheet | |||||
| Cash & Short-Term Investments | $ 1.11B | $ 642.27M | $ 123.10M | $ 256.01M | $ 376.57M |
| Total Assets | $ 1.19B | $ 691.23M | $ 165.08M | $ 306.32M | $ 425.66M |
| Total Debt | $ 20.28M | $ 23.99M | $ 27.41M | $ 30.48M | $ 32.64M |
| Net Debt | $ -873.09M | $ -411.46M | $ -94.21M | $ -141.66M | $ -168.19M |
| Total Liabilities | $ 214.83M | $ 61.40M | $ 73.79M | $ 53.96M | $ 57.47M |
| Stockholders' Equity | $ 972.13M | $ 629.84M | $ 91.29M | $ 252.36M | $ 368.20M |
| Cash Flow | |||||
| Free Cash Flow | $ -405.13M | $ -294.75M | $ -188.89M | $ -156.71M | $ -123.18M |
| Operating Cash Flow | $ -403.21M | $ -292.37M | $ -188.16M | $ -153.65M | $ -119.56M |
| Investing Cash Flow | $ -28.75M | $ -204.08M | $ 83.31M | $ 87.20M | $ -137.89M |
| Financing Cash Flow | $ 890.31M | $ 809.89M | $ 54.32M | $ 37.39M | $ 157.82M |